Data / Form D filings / Accufy Diagnostics, Inc.
Accufy Diagnostics, Inc.: Form D filings
Accufy Diagnostics, Inc., a biotechnology company in Rockville, MD, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on October 28, 2026, reports $2 million sold of a $2 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13 TAFT COURT SUITE 219, Rockville, MD, 20850
- Phone
- (301) 788-8508
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2089723
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | New notice | $2,000,000 | $2,000,000 | 3 | Oct 15, 2026 | sec.gov | |
| Oct 2, 2025 | New notice | $200,000 | $200,000 | 1 | Sep 23, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Hung | Executive Officer, Director | |
| Zhixiong Xu | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
Every Form D from the week of Oct 26, 2026 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Accufy Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.